Multitarget Fecal Immunochemical Test in Stool-Based Colorectal Cancer Screening – The ASCO Post
In a Dutch study reported in The Lancet Oncology, Wisse et al found that a multitarget fecal immunochemical test (mtFIT) improved detection of advanced adenomas vs standard FIT in colorectal cancer screening. The mtFIT used in the study measures hemoglobin, calprotectin, and serpin family F member 2. I ndividuals aged 55 to 75 years eligible for the Dutch national FIT-based colorectal cancer screening program were invited to submit both a FIT and mtFIT sample collected from the same bowel movement.